Codexis (CDXS) Change in Account Payables (2010 - 2026)
Codexis (CDXS) recorded quarterly Change in Account Payables of $312000.0 in Q1 2026, up 139.34% quarter-over-quarter from -$793000.0 in Q4 2025, and down 84.89% on a YoY basis from $2.1 million in Q1 2025.
Codexis (CDXS) Change in Account Payables (2010 - 2026) Analysis & Trends
Codexis' Change in Account Payables history runs 17 years deep, the most recent figure standing at $312000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 84.89% year-over-year to $312000.0; the TTM figure through Mar 2026 stood at -$3.0 million (down 297.85% YoY), while the FY2025 annual figure was -$1.3 million, up 49.9% from the prior year.
- Change in Account Payables was $312000.0 for Q1 2026 at Codexis, up from -$793000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.4 million in Q4 2023 to a low of -$3.5 million in Q2 2025.
- Historically, Change in Account Payables has averaged -$61588.2 across 5 years, with a median of $71000.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables surged 336.69% in 2022, then plunged 1361.18% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $558000.0 in 2022, then soared by 328.67% to $2.4 million in 2023, then plunged by 151.34% to -$1.2 million in 2024, then jumped by 35.42% to -$793000.0 in 2025, then soared by 139.34% to $312000.0 in 2026.
- The last three Change in Account Payables figures came in at $312000.0 (Q1 2026), -$793000.0 (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | -793,000.00 |
| Dec 31, 2025 | -793,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | -3.46 Mn |
| Jun 30, 2025 | -3.46 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Sep 30, 2024 | 936,000.00 |
| Sep 30, 2024 | 936,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Mar 31, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Dec 31, 2023 | 2.39 Mn |
| Dec 31, 2023 | 2.39 Mn |